Aclaris Therapeutics, Inc.

ACRS·NasdaqGS·Healthcare
Compare
3.6800−0.0600 (−1.60%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3.7400
Open3.8100
Day range3.63003.8700
52-week range2.10006.6000
Off day high−4.91%
Off 52-week high−44.24%
Volume2.04M
Avg. volume (3M)2.84M
Market cap570.34M
EPS (TTM)-0.5800
Forward P/E-5.10
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.94
Shares outstanding154.98M
Short interest11.59% of float
Earnings dateAug 6, 2026 (est.)
Analyst target10.3636
Profit margin0.00%

Against its peers

Compare in full ›
ACRS CRVS ATTO ARTV ODTX 8SJ.F
Market cap 570.34M 889.16M 712.16M 206.32M 937.14M 1.84B
P/E (TTM) — — — — — —
Forward P/E -5.1 -9.9 -6.6 -2.1 -4.5 —
Price/book 4.1 3.9 -0.5 0.6 -0.1 2.4
Dividend yield — — — — — —
1-year change +62.11% +35.17% −30.27% +22.67% +31.36% −40.07%
Today −1.60% +7.53% +2.16% +0.48% −9.60% +1.70%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ACRS news ›

From the 4Search news index, newest first.

In the news

5mentions in 30 days
5with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance